Dose-response and potential thresholds in tumour development.
暂无分享,去创建一个
Franz Oesch | Carsten Weiss | Cornelia Dietrich | Barbara Oesch-Bartlomowicz | F. Oesch | C. Dietrich | C. Weiss | B. Oesch-Bartlomowicz
[1] M E Andersen,et al. Mechanistic modeling of rodent liver tumor promotion at low levels of exposure: an example related to dose-response relationships for 2,3,7,8-tetrachlorodibenzo-p-dioxin , 1998, Human & experimental toxicology.
[2] Abraham Nyska,et al. Dose-Additive Carcinogenicity of a Defined Mixture of “Dioxin-like Compounds” , 2004, Environmental health perspectives.
[3] G. Clark,et al. Dose response for TCDD promotion of hepatocarcinogenesis in rats initiated with DEN: histologic, biochemical, and cell proliferation endpoints. , 1993, Environmental health perspectives.
[4] M E Andersen,et al. Hepatic foci in rats after diethylnitrosamine initiation and 2,3,7,8-tetrachlorodibenzo-p-dioxin promotion: evaluation of a quantitative two-cell model and of CYP 1A1/1A2 as a dosimeter. , 1997, Toxicology and applied pharmacology.
[5] H M Bolt,et al. Challenging dogma: thresholds for genotoxic carcinogens? The case of vinyl acetate. , 2003, Annual review of pharmacology and toxicology.
[6] S. Fukushima,et al. Hormesis and dose-response-mediated mechanisms in carcinogenesis: evidence for a threshold in carcinogenicity of non-genotoxic carcinogens. , 2005, Carcinogenesis.
[7] M. Schwarz,et al. Carcinogenic risks of dioxin: mechanistic considerations. , 2005, Regulatory toxicology and pharmacology : RTP.
[8] G. Clark,et al. Ovarian hormones enhance 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated increases in cell proliferation and preneoplastic foci in a two-stage model for rat hepatocarcinogenesis. , 1991, Cancer research.
[9] G. Lucier,et al. Differences in kinetics of induction and reversibility of TCDD-induced changes in cell proliferation and CYP1A1 expression in female Sprague-Dawley rat liver. , 1998, Carcinogenesis.
[10] T. Mikami,et al. Comparison of the mutational spectra of the lacZ transgene in four organs of the MutaMouse treated with benzo[a]pyrene: target organ specificity. , 2000, Mutation research.
[11] G. Jenkins,et al. Do dose response thresholds exist for genotoxic alkylating agents? , 2005, Mutagenesis.
[12] T. Fox,et al. Gene expression and cell proliferation in rat liver after 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure. , 1993, Cancer research.
[13] F. Oesch,et al. Metabolic Detoxification: Implications for Thresholds , 2000, Toxicologic pathology.
[14] F. Oesch,et al. 2,3,7,8-tetrachlorodibenzo-p-dioxin-dependent release from contact inhibition in WB-F344 cells: involvement of cyclin A. , 2002, Toxicology and applied pharmacology.
[15] L Edler,et al. Modeling the number and size of hepatic focal lesions following exposure to 2,3,7,8-TCDD. , 1996, Toxicology and applied pharmacology.
[16] Muller Jja,et al. Tumorigenic effects in Wistar rats orally administered benzo[a] pyrene for two years (gavage studies). Implications for human cancer risks associated with oral exposure to polycyclic aromatic hydrocarbons , 2002 .
[17] C. Weiss,et al. Complementation of Ah receptor deficiency in hepatoma cells: negative feedback regulation and cell cycle control by the Ah receptor. , 1996, Experimental cell research.
[18] A. Koff,et al. p27Kip1 induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells , 1999 .
[19] M. Yamada,et al. Semi-quantitative evaluation of genotoxic activity of chemical substances and evidence for a biological threshold of genotoxic activity. , 2000, Mutation research.
[20] A. Buchmann,et al. Inhibition of apoptosis during 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated tumour promotion in rat liver. , 1995, Carcinogenesis.
[21] C. Wade,et al. Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. , 1978, Toxicology and applied pharmacology.
[22] T. Tsukamoto,et al. Lack of initiation activity in rat liver of low doses of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. , 2003, Cancer letters.
[23] Y. Dragan,et al. Quantitative analysis of dose- and time-dependent promotion of four phenotypes of altered hepatic foci by 2,3,7,8-tetrachlorodibenzo-p-dioxin in female Sprague-Dawley rats. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.
[24] S. J. Culp,et al. DNA Adduct Measurements in Relation to Small Intestine and Forestomach Tumor Incidence during the Chronic Feeding of Coal TAR or Benzo[A]Pyrene to Mice , 1996 .
[25] G L Kimmel,et al. Developmental and reproductive toxicity of dioxins and related compounds: cross-species comparisons. , 1993, Critical reviews in toxicology.
[26] D W Gaylor,et al. A comparison of the tumors induced by coal tar and benzo[a]pyrene in a 2-year bioassay. , 1998, Carcinogenesis.
[27] M. DeVito,et al. Dose-response relationships in mice following subchronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin: CYP1A1, CYP1A2, estrogen receptor, and protein tyrosine phosphorylation. , 1994, Toxicology and applied pharmacology.
[28] T. Tsukamoto,et al. Lack of a Dose‐response Relationship for Carcinogenicity in the Rat Liver with Low Doses of 2‐Amino‐3,8‐dimethylimidazo[4,5‐f]quinoxaline or N‐Nitrosodiethylamine , 2002, Japanese journal of cancer research : Gann.
[29] R. Conolly,et al. Nonmonotonic dose-response relationships: mechanistic basis, kinetic modeling, and implications for risk assessment. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.